期刊文献+

内皮素与高血压患者血压水平及左室肥厚的相关性研究 被引量:1

Relationship between the endothelin and blood pressure and left ventricular hypertrophy in essential hypertension
下载PDF
导出
摘要 目的 :探讨高血压病 (EH)患者血浆内皮素 (ET)浓度与血压水平及左室肥厚 (LVH)的关系 ;方法 :高血压组 49例 ,正常对照组 2 0例。以特异性放射免疫方法测定血浆ET水平 ,超声心动图诊断LVH ;结果 :EH组血浆ET(90 2 3± 2 2 2 6pg ml)显著高于正常对照组 (66 88± 1 6.0 5 pg ml,P <0 0 1 ) ,轻度EH时ET(83 5 7± 2 2 .2 7pg ml)已有升高 ,中重度 (98 5 4± 2 2 3 4pg ml)高于轻度 (P <0 0 1 ) ,血浆ET与血压水平呈正相关 (r =0 65 7,P <0 0 1 )。EH合并LVH组ET(1 41 0 3± 2 5 78pg ml)较不合并LVH组 (85 1 0± 1 9 91 pg ml)显著增高 (P <0 0 1 ) ,ET值与左室心肌重量指数 (LV MI)呈正相关 (r =0 41 8,P <0 0 1 )。结论 :ET与血压升高关系密切 ,ET对EH的发生及LVH的形成有重要作用。 Objective:To study the relationship between changes of plasma endothelin(ET) and blood pressure and left ventricular hypertrophy(LVH)in patients with essential hypertension(EH);Methods:The plasma ET level were decteded by radioimmunoassay(RIA)method in patients with hypertension(49)and normotensive subjects(20),LVH were determined by echocardiography;Results:The plasma ET level in EH patients was higher than that in normal subjects(90.23±22.26 VS 66.88±16.05pg/ml,P<0 01).ET was in creased in mild hypertensive group(83 57±22 27pg/ml),it was obviously higher in moderate and severe hypertensive group(98 54±22 34pg/ml) than in mild group(P<0 01).It was positively correlated with mean artery pressure(r=0.657,P<0.01).The plasma of ET in the group of essential hypertension with LVH were higher than in those without LVH(141.03±25.78 VS 85.10±19.91pg/ml,P<0.01).It was positively correlated with left Ventricular mass index in all patients.Conclusion:It is suggested that ET is closely related with the rise of blood pressure and may play a role in the production and development of hypertension and LVH.[
出处 《内蒙古医学杂志》 2000年第2期92-94,共3页 Inner Mongolia Medical Journal
关键词 内皮素 高血压 左室肥厚 并发症 endothelin hypertension left ventricular hypertrophy
  • 相关文献

参考文献3

二级参考文献35

共引文献127

同被引文献17

  • 1张晨晖,李倩虹,周洪,张新波,周爱儒,汤健.自发性高血压大鼠内皮素A型受体基因的表达[J].中国高血压杂志,1994,2(2):77-79. 被引量:8
  • 2汤健 唐朝枢 杨军 等.内皮素[M].北京:北京医科大学北京协和医科大学联合出版社,1993.277-279.
  • 3Dahlof B,Devereux R,De Faire U,et al.The losartan intervention for endpoint reduction(LIFE)in hypertension study:rationale,design and methods The LIFE study group[M].Am Hypertens,1997:705.
  • 4Yanagisawa M,Kurihara H,Moncada S.Nitric oxide release accounts for the biologic activity of endothelium derived relaxing factor[J].Nature,1987,328:524.
  • 5Tamirisa P,Frishman WH,Kumar A.Endothelin and endothelin antagonism.Role in cardiovascular health and disease[J].Am Heart J,1995,130(3ptl):601.
  • 6Yanagisawa M,Kurihara H,Kimura S,et al.A novel potent vasoconstrictor peptide produced by vascular endothelial cells[J].Nature,1988,332(6163):414.
  • 7Marban E.Intracellular calcium,proto-oncogenes and cardiac hypertrophy[J].Hypertension,1990,15(6ptl):652.
  • 8Resenfeld M G,Merdod J J,Amara S G,et al.Production of a novel neuropeptide encoded by the calcitonin gene via tissue -specific RNA processing[J].Nature,1983,304(5922):129.
  • 9De Hoon JN,Pickkers P,Smits P,et al.Calcitonin gene-related peptide:exploring its vasodilating mechanism of action in humans[J].Clin Pharmacol Ther,2003,73:312.
  • 10Yamada M,lshikawa T,Fujimori A,et al.Enhanced depressor and hyperemic responses to calcitonin gene-related peptide in spontaneously hypertensive rats[J].Peptides,1998,19:697.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部